noted renal TFAM deficiency and mtDNA damage in patients with IR-AKI; in the mouse model, mtROS disrupted TFAM and mtDNA homeostasis by inhibiting renal TFAM transcription and promoting its degradation, thereby driving mtDNA release and renal inflammatory response (88). Here, TFAM is linked to acute kidney injury.